FDA, Healthcare Provider, Pharmacology and Physicians

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

FDA

Healthcare Provider

Pharmacology

Physicians

The potential of virtual reality-based therapy for serious mental disorders

Pharmaceutical Technology

AUGUST 12, 2022

In June this year, it was announced that the US Food and Drug Administration (FDA) had granted UK-based OxfordVR a breakthrough device designation for its gameChangeVR treatment to deliver immersive cognitive behaviour therapy (CBT) to people suffering from schizophrenia and other mental illnesses. million people in the UK and 2.7

Food and Drug Administration

Food and Drug Administration Pharmacology Side effects Physicians

Why aren’t digital pills taking off?

Pharmaceutical Technology

AUGUST 8, 2022

In 2017, the US Food and Drug Administration (FDA) broke ground by approving the first drug with an embedded biosensor to track its use. Yet, despite the landmark FDA approval, digital pills have not exploded in pharma. It potentially helps individuals lend some kind of concrete evidence to discussions with their healthcare provider.

Food and Drug Administration

Food and Drug Administration FDA Medicine Patients

Pharma Rep Focus

The potential of virtual reality-based therapy for serious mental disorders

Why aren’t digital pills taking off?

Stay Connected